Mihoko Shibuya

619 total citations
15 papers, 494 citations indexed

About

Mihoko Shibuya is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mihoko Shibuya has authored 15 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 5 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mihoko Shibuya's work include T-cell and B-cell Immunology (5 papers), Vasculitis and related conditions (4 papers) and Immune Cell Function and Interaction (3 papers). Mihoko Shibuya is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Vasculitis and related conditions (4 papers) and Immune Cell Function and Interaction (3 papers). Mihoko Shibuya collaborates with scholars based in Japan and United States. Mihoko Shibuya's co-authors include Keishi Fujio, Kazuhiko Yamamoto, Hirofumi Shoda, Shuji Sumitomo, Tomohisa Okamura, Shimon Sakaguchi, Hiroaki Harada, Kaoru Morita, Akiko Okamoto and Hiroko Kanda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Mihoko Shibuya

15 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mihoko Shibuya Japan	10	233	110	106	82	52	15	494
Marek Masiuk Poland	12	249 1.1×	137 1.2×	75 0.7×	195 2.4×	53 1.0×	31	618
Elena Pipi United Kingdom	13	171 0.7×	79 0.7×	118 1.1×	66 0.8×	37 0.7×	19	495
Will G. James Australia	10	440 1.9×	64 0.6×	103 1.0×	111 1.4×	38 0.7×	10	617
Mark F. R. Vondenhoff Netherlands	8	470 2.0×	212 1.9×	75 0.7×	145 1.8×	32 0.6×	9	698
Jacky Bismuth France	17	303 1.3×	142 1.3×	52 0.5×	112 1.4×	14 0.3×	18	1.1k
Dominique Bernard France	11	197 0.8×	68 0.6×	110 1.0×	204 2.5×	38 0.7×	16	591
Fehim Esen Türkiye	13	204 0.9×	72 0.7×	69 0.7×	166 2.0×	47 0.9×	47	678
Ivy Y. Choi Netherlands	12	179 0.8×	78 0.7×	217 2.0×	158 1.9×	22 0.4×	15	475
Kentaro Ohara Japan	16	102 0.4×	123 1.1×	57 0.5×	170 2.1×	112 2.2×	54	636
Narges Seyfizadeh Iran	12	190 0.8×	97 0.9×	29 0.3×	156 1.9×	26 0.5×	20	474

Countries citing papers authored by Mihoko Shibuya

Since Specialization

Citations

This map shows the geographic impact of Mihoko Shibuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihoko Shibuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihoko Shibuya more than expected).

Fields of papers citing papers by Mihoko Shibuya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihoko Shibuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihoko Shibuya. The network helps show where Mihoko Shibuya may publish in the future.

Co-authorship network of co-authors of Mihoko Shibuya

This figure shows the co-authorship network connecting the top 25 collaborators of Mihoko Shibuya. A scholar is included among the top collaborators of Mihoko Shibuya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihoko Shibuya. Mihoko Shibuya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ihara, Ryoko, Akiko Kishi, Kenji Kirihara, et al.. (2018). Safety and pharmacokinetics of single and repeated dose of a novel formulation of intra-nasal Oxytocin (TTA-121) in healthy Japanese volunteers (double blind, placebo-controlled Phase 1 trial). Proceedings for Annual Meeting of The Japanese Pharmacological Society. WCP2018(0). OR6–3. 4 indexed citations

Kataoka, Hideki, Tatsunori Ikemoto, Mihoko Shibuya, et al.. (2017). Association of early physical activity time with pain, activities of daily living, and progression of vertebral body collapse in patients with vertebral compression fractures. European Journal of Physical and Rehabilitation Medicine. 53(3). 366–376. 9 indexed citations

Tsukui, Daisuke, Hiroko Kanda, Aya Shinozaki‐Ushiku, et al.. (2017). Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome. Modern Rheumatology. 28(4). 621–625. 9 indexed citations

Taniguchi, Yuki, Hirotaka Chikuda, Yasushi Oshima, et al.. (2016). Thoracic intradural extramedullary lesions causing progressive myelopathy as an initial manifestation of granulomatosis with polyangiitis: a case report and review of literature. Journal of Spinal Cord Medicine. 40(1). 122–125. 2 indexed citations

Shibuya, Mihoko, Keishi Fujio, Hirofumi Shoda, et al.. (2015). A new T‐cell activation mode for suboptimal doses of antigen under the full activation of T cells with different specificity. European Journal of Immunology. 45(6). 1643–1653. 4 indexed citations

Shoda, Hirofumi, Keishi Fujio, Keiichi Sakurai, et al.. (2015). Autoantigen BiP‐Derived HLA–DR4 Epitopes Differentially Recognized by Effector and Regulatory T Cells in Rheumatoid Arthritis. Arthritis & Rheumatology. 67(5). 1171–1181. 22 indexed citations

Tsuchida, Yumi, Mihoko Shibuya, Hirofumi Shoda, et al.. (2014). Characteristics of granulomatosis with polyangiitis patients in Japan. Modern Rheumatology. 25(2). 219–223. 14 indexed citations

Shibuya, Mihoko, Keishi Fujio, Kaoru Morita, et al.. (2013). Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis. Modern Rheumatology. 23(3). 577–581. 24 indexed citations

Komai, Toshihiko, Hirofumi Shoda, Kenichi Yamaguchi, et al.. (2013). Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report. Modern Rheumatology. 26(2). 294–296. 38 indexed citations

10.

Sumitomo, Shuji, Keishi Fujio, Tomohisa Okamura, et al.. (2013). Transcription Factor Early Growth Response 3 Is Associated with the TGF-β1 Expression and the Regulatory Activity of CD4-Positive T Cells In Vivo. The Journal of Immunology. 191(5). 2351–2359. 20 indexed citations

11.

Shibuya, Mihoko, Keishi Fujio, Kaoru Morita, et al.. (2012). Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis. Modern Rheumatology. 23(3). 577–581. 27 indexed citations

12.

Shoda, Hirofumi, Keishi Fujio, Mihoko Shibuya, et al.. (2011). Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis. Arthritis Research & Therapy. 13(6). R191–R191. 66 indexed citations

13.

Okamura, Tomohisa, Keishi Fujio, Mihoko Shibuya, et al.. (2009). CD4⁺CD25⁻LAG3⁺regulatory T cells controlled by the transcription factor Egr-2. Proceedings of the National Academy of Sciences. 106(33). 13974–13979. 185 indexed citations

14.

Izutsu, Takashi, Mihoko Shibuya, Atsuro Tsutsumi, Takako Konishi, & Noriyuki Kawamura. (2008). The Relationship Between Past Traumatic Experience and Sickness Absence. International Journal of Social Psychiatry. 54(1). 83–89. 5 indexed citations

15.

Okunishi, Katsuhide, Makoto Dohi, Keishi Fujio, et al.. (2007). Hepatocyte Growth Factor Significantly Suppresses Collagen-Induced Arthritis in Mice. The Journal of Immunology. 179(8). 5504–5513. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact